ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 606985 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 606985; 2) Community: the network communities that were significantly associated with the response to NSC 606985; 3) Molecule: the relationships between components within communities and NSC 606985; 4) MDR: the compounds that were significantly associated with the NSC 606985.

NSC Compound Enrichment Correlation
NSC 740385 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide 0.0459335986102865 -0.013772514
NSC 748533 1-[2-(3-Chlorophenyl)-2-oxoethyl]-2-acetylbenzimidazole 0.0459335986102865 0.18855883
NSC 756251 GW559768X 0.0459335986102865 -0.24711843
NSC 756698 Clomiphene citrate (USAN) 0.0459335986102865 0.14214272
NSC 758664 Sirolimus [USAN] 0.0459335986102865 -0.054500461
NSC 94600 Camptothecin 0.0459335986102865 0.84549594
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0474314077111075 0.076030466
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.0474314077111075 0.12390098
NSC 253272 Acetamide, N-[(methylamino)carbonyl]-N-[[(methylamino)carbonyl]oxy]- (9CI) 0.0474314077111082 0.12141853
NSC 172614 9H-Purin-2-amine, 9-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.048939380959983 0.36778299
Total:88  Current:84    [First] [Prev] [Next] [Last]